Carmell Therapeutics Corp... (CTCX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.55
11.11%
At close: Jan 13, 2025, 3:08 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 |
PE Ratio | -2.72 | -21.67 | -29.35 |
PS Ratio | n/a | n/a | n/a |
PB Ratio | 1.70 | -5.19 | -6.43 |
P/FCF Ratio | -5.01 | -57.08 | -160.61 |
P/OCF Ratio | -5.03 | -57.2 | -161.6 |
OCF/S Ratio | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | -0.07 | -0.29 |
Quick Ratio | 1.63 | 0.08 | 0.01 |
Current Ratio | 1.63 | 0.08 | 0.01 |
Asset Turnover | n/a | n/a | n/a |
Interest Coverage | -5.87 | -1.47 | -0.78 |
Return on Equity (ROE) | -0.62 | 0.24 | 0.22 |
Return on Assets (ROA) | -0.24 | -5.18 | -4.16 |
Return on Capital (ROIC) | -0.21 | 0.99 | 0.14 |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a |